Research

Hormonal

Soluble GPNMB (sGPNMB) promotes lipogenesis in white adipose tissue by activating SREBP1c via CD44 binding, thereby acting as a risk factor for obesity progression.

This research highlights that obesity involves complex signaling where soluble proteins released by fat cells can drive further fat storage. While not a direct lifestyle intervention, understanding this mechanism underscores why reducing adiposity (via caloric deficit and exercise) is crucial, as it reduces the source of these pro-lipogenic signals.

ModerateSupportsMEDIUM confidence
sGPNMB was also described as a hepatokine that activates SREBP1c and thus lipogenesis in obese WAT by binding CD44 on adipocytes, resulting in a positive correlation between sGPNMB and BMI [86]. These findings indicate that GPNMB is a strong risk factor for obesity.
Valentina Bianco et al. · Experimental and Clinical Endocrinology & Diabetes · 2023

Why this rating

The paper is a review summarizing multiple studies (mostly murine models); direct human clinical trial data for this specific mechanism is not the primary focus.

Source

Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity

Valentina Bianco et al. · Experimental and Clinical Endocrinology & Diabetes · 2023

DOI 10.1055/a-2192-0101

narrative_reviewCited 11×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →